Vanguard Capital Management’s Larimar Therapeutics LRMR Stock Holding History
Bought
Maintained
Sold
Other funds holding LRMR
Vanguard Capital Management's LRMR Position: Q3 2026 in Review
Vanguard Capital Management held its Larimar Therapeutics (LRMR) position steady in Q3 2026 at 2,974,901 shares worth $9.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2786.
Vanguard Capital Management first reported a position in LRMR in Q1 2026 and has held it in 3 quarters since. The position peaked at $12.9M in Q1 2026. 146 funds tracked by Wall St. Rank hold LRMR as of Q3 2026.
- Vanguard Capital Management held 2,974,901 shares of Larimar Therapeutics worth $9.5M as of Q3 2026.
- Vanguard Capital Management left its Larimar Therapeutics share count unchanged in Q3 2026.
- Larimar Therapeutics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #2786 holding.
- Vanguard Capital Management first reported a position in Larimar Therapeutics in Q1 2026 and has held it in 3 quarters since.
- Vanguard Capital Management's Larimar Therapeutics position peaked at $12.9M in Q1 2026.
- 146 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q3 2026.
Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.